All articles by Andy Extance – Page 17
-
ResearchBubble wrap could send lab costs packing
Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries
-
ResearchLinguistic statistics enable synthetic prophetics
A metric more commonly used by search engines to analyse language can now power organic chemistry retrosyntheses
-
ResearchAlloy primed for phase change from CD to TV
Uniting optical and electronic properties could bring compact disc material into smart contact lenses
-
ResearchMolecular sieve membranes look to greener separations
Coating micron-scale fibres’ inner surfaces with a MOF membrane could slash propylene production energy consumption
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
FeatureBeyond wonder
Five artists show Andy Extance why science and art need not be mutually exclusive
-
NewsNickel allergy case highlights nanoparticle unknowns
Chemist’s metal hypersensitivity after weighing powder on open bench underlines safety needs
-
BusinessPharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
ResearchCluster structure promises acid advance
After a 40-year wait, new information on how water clusters around protons stands to benefit our understanding of acids.
-
FeatureReaching out
Andy Extance surveys how pharma uses outsourcing in a variety of different ways
-
ResearchMechanism study seeks to clear ‘crystalline flask’ cloud
Could x-ray crystallography tracking of palladium-mediated aromatic bromination herald a flood of similar research?
-
BusinessPfizer presses hard for AstraZeneca deal
Executives face down international controversy over tax schemes and previous post-merger record
-
BusinessBayer wins race to buy Merck & Co consumer care
$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
-
-
NewsMIT makes mega-investment in new nano lab
Multidisciplinary approach of $350 million MIT.nano will foster innovation and support investment in ‘state-of-the-art’ tools
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Research
Nanotubes zip into bundle of solar energy
Closely packing photoisomerisable groups together boosts energy storage density of versatile solar thermal fuels
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
BusinessSun set on Ranbaxy rescue
Acquiring beleaguered firm will create India’s biggest pharmaceutical company
-
Research
Rotaxanes make symmetry history
Synthesis and separation of mechanically chiral rotaxanes after more than 40 years is ‘a major breakthrough’